Avricore Health (AVCRF) Gross Profit (2009 - 2025)

Avricore Health has disclosed Gross Profit across 15 years of filings, most recently posting -$38221.0 for Q3 2025.

• In Q3 2025, Gross Profit fell 111.99% year-over-year to -$38221.0; the TTM figure through Sep 2025 stood at $487133.3 (down 63.04% YoY), while the FY2025 annual figure was $170552.8, down 87.58% from the prior year.
• Gross Profit slipped to -$38221.0 in Q3 2025, from -$34710.8 in the prior quarter.
• Over the last five years, Gross Profit for AVCRF reached as high as $368344.6 in Q4 2023 and fell as low as -$38221.0 in Q3 2025.
• The 5-year median for Gross Profit is $140114.3 (2023), against an average of $132166.7.
• Annual changes were most pronounced in 2021 — Gross Profit plunged 122.92% — and 2022, when it jumped 5594.34%.
• A 5-year view of Gross Profit shows it stood at $7391.5 in 2021, then surged by 1582.86% to $124388.6 in 2022, then jumped by 196.12% to $368344.6 in 2023, then fell by 13.47% to $318725.0 in 2024, then plunged by 111.99% to -$38221.0 in 2025.
• According to Business Quant data, Gross Profit over the past three periods registered -$38221.0, -$34710.8, and $241340.1 for Q3 2025, Q2 2025, and Q1 2025 respectively.